Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally. The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism. It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pregabalin capsule; and Memantine Hydrochloride tablets and Pioglitazone tablets USP. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is headquartered in Haikou, the People's Republic of China.
Research context
Hainan Shuangcheng Pharmaceuticals Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Hainan Shuangcheng Pharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 3.9% below its 200 day moving average.
From a valuation standpoint, the stock is 35.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.2.
Hainan Shuangcheng Pharmaceuticals Co., Ltd's total revenue sank by 0.9% to $76M since the same quarter in the previous year.
Its net income has dropped by 118.6% to $-9M since the same quarter in the previous year.
Finally, its free cash flow grew by 90.9% to $15M since the same quarter in the previous year.
Based on the above factors, Hainan Shuangcheng Pharmaceuticals Co., Ltd gets an overall score of 2/5.